Regeneron Pharmaceuticals Expands Gene Editing Capabilities with Mammoth Biosciences Partnership

Regeneron, Mammoth Biosciences, gene editing, CRISPR, partnership, biotechnology, healthcare, pharmaceuticals, genetic research, therapeutic development.

Revolutionizing Gene Editing: Regeneron and Mammoth Biosciences’ $100M Partnership

Regeneron, Mammoth Biosciences, CRISPR, gene editing, delivery system, therapeutics, collaboration, biotechnology, healthcare innovation.